Canine Atopic Dermatitis Treatment
Canine Atopic Dermatitis Treatment market is segmented by players, region (country), by Type and ... Read More
Global Cancer Drugs Market Insights and Forecast to 2028
1 Study Coverage
1.1 Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Cancer Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cancer Drugs Sales by Region
2.4.1 Global Cancer Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Cancer Drugs by Region (2023-2028)
2.5 Global Cancer Drugs Revenue by Region
2.5.1 Global Cancer Drugs Revenue by Region (2017-2022)
2.5.2 Global Cancer Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cancer Drugs Sales by Manufacturers
3.1.1 Global Top Cancer Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Cancer Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Drugs in 2021
3.2 Global Cancer Drugs Revenue by Manufacturers
3.2.1 Global Cancer Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Cancer Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Drugs Revenue in 2021
3.3 Global Cancer Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cancer Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Drugs Sales by Type
4.1.1 Global Cancer Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Cancer Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Cancer Drugs Sales Market Share by Type (2017-2028)
4.2 Global Cancer Drugs Revenue by Type
4.2.1 Global Cancer Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Cancer Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cancer Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Cancer Drugs Price by Type
4.3.1 Global Cancer Drugs Price by Type (2017-2022)
4.3.2 Global Cancer Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cancer Drugs Sales by Application
5.1.1 Global Cancer Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Cancer Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Cancer Drugs Sales Market Share by Application (2017-2028)
5.2 Global Cancer Drugs Revenue by Application
5.2.1 Global Cancer Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Cancer Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cancer Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Cancer Drugs Price by Application
5.3.1 Global Cancer Drugs Price by Application (2017-2022)
5.3.2 Global Cancer Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cancer Drugs Market Size by Type
6.1.1 North America Cancer Drugs Sales by Type (2017-2028)
6.1.2 North America Cancer Drugs Revenue by Type (2017-2028)
6.2 North America Cancer Drugs Market Size by Application
6.2.1 North America Cancer Drugs Sales by Application (2017-2028)
6.2.2 North America Cancer Drugs Revenue by Application (2017-2028)
6.3 North America Cancer Drugs Market Size by Country
6.3.1 North America Cancer Drugs Sales by Country (2017-2028)
6.3.2 North America Cancer Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cancer Drugs Market Size by Type
7.1.1 Europe Cancer Drugs Sales by Type (2017-2028)
7.1.2 Europe Cancer Drugs Revenue by Type (2017-2028)
7.2 Europe Cancer Drugs Market Size by Application
7.2.1 Europe Cancer Drugs Sales by Application (2017-2028)
7.2.2 Europe Cancer Drugs Revenue by Application (2017-2028)
7.3 Europe Cancer Drugs Market Size by Country
7.3.1 Europe Cancer Drugs Sales by Country (2017-2028)
7.3.2 Europe Cancer Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cancer Drugs Market Size by Type
8.1.1 Asia Pacific Cancer Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Cancer Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Cancer Drugs Market Size by Application
8.2.1 Asia Pacific Cancer Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Cancer Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Cancer Drugs Market Size by Region
8.3.1 Asia Pacific Cancer Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Cancer Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cancer Drugs Market Size by Type
9.1.1 Latin America Cancer Drugs Sales by Type (2017-2028)
9.1.2 Latin America Cancer Drugs Revenue by Type (2017-2028)
9.2 Latin America Cancer Drugs Market Size by Application
9.2.1 Latin America Cancer Drugs Sales by Application (2017-2028)
9.2.2 Latin America Cancer Drugs Revenue by Application (2017-2028)
9.3 Latin America Cancer Drugs Market Size by Country
9.3.1 Latin America Cancer Drugs Sales by Country (2017-2028)
9.3.2 Latin America Cancer Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cancer Drugs Market Size by Type
10.1.1 Middle East and Africa Cancer Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cancer Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Cancer Drugs Market Size by Application
10.2.1 Middle East and Africa Cancer Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cancer Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Cancer Drugs Market Size by Country
10.3.1 Middle East and Africa Cancer Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Celgene
11.3.1 Celgene Corporation Information
11.3.2 Celgene Overview
11.3.3 Celgene Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celgene Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgene Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bristol-Myers Squibb Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Overview
11.5.3 Amgen Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Amgen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amgen Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Takeda
11.8.1 Takeda Corporation Information
11.8.2 Takeda Overview
11.8.3 Takeda Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Takeda Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Takeda Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Corporation Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Astellas
11.11.1 Astellas Corporation Information
11.11.2 Astellas Overview
11.11.3 Astellas Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Astellas Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Astellas Recent Developments
11.12 Merck & Co.
11.12.1 Merck & Co. Corporation Information
11.12.2 Merck & Co. Overview
11.12.3 Merck & Co. Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Merck & Co. Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck & Co. Recent Developments
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sanofi Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Bayer
11.14.1 Bayer Corporation Information
11.14.2 Bayer Overview
11.14.3 Bayer Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Bayer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bayer Recent Developments
11.15 Biogen Idec
11.15.1 Biogen Idec Corporation Information
11.15.2 Biogen Idec Overview
11.15.3 Biogen Idec Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Biogen Idec Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Biogen Idec Recent Developments
11.16 Eisai
11.16.1 Eisai Corporation Information
11.16.2 Eisai Overview
11.16.3 Eisai Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Eisai Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Eisai Recent Developments
11.17 Teva
11.17.1 Teva Corporation Information
11.17.2 Teva Overview
11.17.3 Teva Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Teva Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Teva Recent Developments
11.18 Otsuka
11.18.1 Otsuka Corporation Information
11.18.2 Otsuka Overview
11.18.3 Otsuka Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Otsuka Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Otsuka Recent Developments
11.19 Merck KGaA
11.19.1 Merck KGaA Corporation Information
11.19.2 Merck KGaA Overview
11.19.3 Merck KGaA Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Merck KGaA Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Merck KGaA Recent Developments
11.20 Ipsen
11.20.1 Ipsen Corporation Information
11.20.2 Ipsen Overview
11.20.3 Ipsen Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Ipsen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Ipsen Recent Developments
11.21 AbbVie
11.21.1 AbbVie Corporation Information
11.21.2 AbbVie Overview
11.21.3 AbbVie Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 AbbVie Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 AbbVie Recent Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Corporation Information
11.22.2 Gilead Sciences Overview
11.22.3 Gilead Sciences Cancer Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Gilead Sciences Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Gilead Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Drugs Industry Chain Analysis
12.2 Cancer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Drugs Production Mode & Process
12.4 Cancer Drugs Sales and Marketing
12.4.1 Cancer Drugs Sales Channels
12.4.2 Cancer Drugs Distributors
12.5 Cancer Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cancer Drugs Industry Trends
13.2 Cancer Drugs Market Drivers
13.3 Cancer Drugs Market Challenges
13.4 Cancer Drugs Market Restraints
14 Key Findings in The Global Cancer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Chemotherapy
Table 3. Major Manufacturers of Targeted Therapy
Table 4. Major Manufacturers of Immunotherapy
Table 5. Major Manufacturers of Hormonal Therapy (Biologic Therapy)
Table 6. Major Manufacturers of Others
Table 7. Global Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Cancer Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 10. Global Cancer Drugs Sales Market Share by Region (2017-2022)
Table 11. Global Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 12. Global Cancer Drugs Sales Market Share by Region (2023-2028)
Table 13. Global Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Cancer Drugs Revenue Market Share by Region (2017-2022)
Table 15. Global Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Cancer Drugs Revenue Market Share by Region (2023-2028)
Table 17. Global Cancer Drugs Sales by Manufacturers (2017-2022) & (K MT)
Table 18. Global Cancer Drugs Sales Share by Manufacturers (2017-2022)
Table 19. Global Cancer Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Cancer Drugs Revenue Share by Manufacturers (2017-2022)
Table 21. Cancer Drugs Price by Manufacturers (2017-2022) &(USD/MT)
Table 22. Global Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drugs as of 2021)
Table 24. Cancer Drugs Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cancer Drugs Product Offered
Table 26. Date of Manufacturers Enter into Cancer Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 29. Global Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 30. Global Cancer Drugs Sales Share by Type (2017-2022)
Table 31. Global Cancer Drugs Sales Share by Type (2023-2028)
Table 32. Global Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Cancer Drugs Revenue Share by Type (2017-2022)
Table 35. Global Cancer Drugs Revenue Share by Type (2023-2028)
Table 36. Cancer Drugs Price by Type (2017-2022) & (USD/MT)
Table 37. Global Cancer Drugs Price Forecast by Type (2023-2028) & (USD/MT)
Table 38. Global Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 39. Global Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 40. Global Cancer Drugs Sales Share by Application (2017-2022)
Table 41. Global Cancer Drugs Sales Share by Application (2023-2028)
Table 42. Global Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Cancer Drugs Revenue Share by Application (2017-2022)
Table 45. Global Cancer Drugs Revenue Share by Application (2023-2028)
Table 46. Cancer Drugs Price by Application (2017-2022) & (USD/MT)
Table 47. Global Cancer Drugs Price Forecast by Application (2023-2028) & (USD/MT)
Table 48. North America Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 49. North America Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 50. North America Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 53. North America Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 54. North America Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 57. North America Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 58. North America Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 61. Europe Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 62. Europe Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 65. Europe Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 66. Europe Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 69. Europe Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 70. Europe Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 73. Asia Pacific Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 74. Asia Pacific Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 77. Asia Pacific Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 78. Asia Pacific Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 81. Asia Pacific Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 82. Asia Pacific Cancer Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Cancer Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 85. Latin America Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 86. Latin America Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 89. Latin America Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 90. Latin America Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 93. Latin America Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 94. Latin America Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 97. Middle East and Africa Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 98. Middle East and Africa Cancer Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Cancer Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 101. Middle East and Africa Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 102. Middle East and Africa Cancer Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Cancer Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 105. Middle East and Africa Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 106. Middle East and Africa Cancer Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Cancer Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 108. Roche Corporation Information
Table 109. Roche Description and Major Businesses
Table 110. Roche Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 111. Roche Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Roche Recent Developments
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Major Businesses
Table 115. Novartis Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 116. Novartis Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novartis Recent Developments
Table 118. Celgene Corporation Information
Table 119. Celgene Description and Major Businesses
Table 120. Celgene Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 121. Celgene Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Celgene Recent Developments
Table 123. Bristol-Myers Squibb Corporation Information
Table 124. Bristol-Myers Squibb Description and Major Businesses
Table 125. Bristol-Myers Squibb Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 126. Bristol-Myers Squibb Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Bristol-Myers Squibb Recent Developments
Table 128. Amgen Corporation Information
Table 129. Amgen Description and Major Businesses
Table 130. Amgen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 131. Amgen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Amgen Recent Developments
Table 133. Johnson & Johnson Corporation Information
Table 134. Johnson & Johnson Description and Major Businesses
Table 135. Johnson & Johnson Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 136. Johnson & Johnson Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Johnson & Johnson Recent Developments
Table 138. Pfizer Corporation Information
Table 139. Pfizer Description and Major Businesses
Table 140. Pfizer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 141. Pfizer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Pfizer Recent Developments
Table 143. Takeda Corporation Information
Table 144. Takeda Description and Major Businesses
Table 145. Takeda Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 146. Takeda Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Takeda Recent Developments
Table 148. Eli Lilly Corporation Information
Table 149. Eli Lilly Description and Major Businesses
Table 150. Eli Lilly Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 151. Eli Lilly Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Eli Lilly Recent Developments
Table 153. AstraZeneca Corporation Information
Table 154. AstraZeneca Description and Major Businesses
Table 155. AstraZeneca Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 156. AstraZeneca Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. AstraZeneca Recent Developments
Table 158. Astellas Corporation Information
Table 159. Astellas Description and Major Businesses
Table 160. Astellas Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 161. Astellas Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Astellas Recent Developments
Table 163. Merck & Co. Corporation Information
Table 164. Merck & Co. Description and Major Businesses
Table 165. Merck & Co. Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 166. Merck & Co. Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Merck & Co. Recent Developments
Table 168. Sanofi Corporation Information
Table 169. Sanofi Description and Major Businesses
Table 170. Sanofi Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 171. Sanofi Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Sanofi Recent Developments
Table 173. Bayer Corporation Information
Table 174. Bayer Description and Major Businesses
Table 175. Bayer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 176. Bayer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Bayer Recent Developments
Table 178. Biogen Idec Corporation Information
Table 179. Biogen Idec Description and Major Businesses
Table 180. Biogen Idec Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 181. Biogen Idec Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Biogen Idec Recent Developments
Table 183. Eisai Corporation Information
Table 184. Eisai Description and Major Businesses
Table 185. Eisai Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 186. Eisai Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Eisai Recent Developments
Table 188. Teva Corporation Information
Table 189. Teva Description and Major Businesses
Table 190. Teva Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 191. Teva Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Teva Recent Developments
Table 193. Otsuka Corporation Information
Table 194. Otsuka Description and Major Businesses
Table 195. Otsuka Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 196. Otsuka Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Otsuka Recent Developments
Table 198. Merck KGaA Corporation Information
Table 199. Merck KGaA Description and Major Businesses
Table 200. Merck KGaA Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 201. Merck KGaA Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Merck KGaA Recent Developments
Table 203. Ipsen Corporation Information
Table 204. Ipsen Description and Major Businesses
Table 205. Ipsen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 206. Ipsen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Ipsen Recent Developments
Table 208. AbbVie Corporation Information
Table 209. AbbVie Description and Major Businesses
Table 210. AbbVie Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 211. AbbVie Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 212. AbbVie Recent Developments
Table 213. Gilead Sciences Corporation Information
Table 214. Gilead Sciences Description and Major Businesses
Table 215. Gilead Sciences Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 216. Gilead Sciences Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 217. Gilead Sciences Recent Developments
Table 218. Key Raw Materials Lists
Table 219. Raw Materials Key Suppliers Lists
Table 220. Cancer Drugs Distributors List
Table 221. Cancer Drugs Customers List
Table 222. Cancer Drugs Market Trends
Table 223. Cancer Drugs Market Drivers
Table 224. Cancer Drugs Market Challenges
Table 225. Cancer Drugs Market Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drugs Product Picture
Figure 3. Global Cancer Drugs Market Share by Type in 2021 & 2028
Figure 3. Chemotherapy Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cancer Drugs Market Share by Application in 2021 & 2028
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory/Lung Cancer
Figure 14. Other Cancers
Figure 15. Cancer Drugs Report Years Considered
Figure 16. Global Cancer Drugs Sales 2017-2028 (K MT)
Figure 17. Global Cancer Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Cancer Drugs Revenue 2017-2028 (US$ Million)
Figure 19. Global Cancer Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Cancer Drugs Sales Market Share by Region (2017-2022)
Figure 21. Global Cancer Drugs Sales Market Share by Region (2023-2028)
Figure 22. North America Cancer Drugs Sales YoY (2017-2028) & (K MT)
Figure 23. North America Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Cancer Drugs Sales YoY (2017-2028) & (K MT)
Figure 25. Europe Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Cancer Drugs Sales YoY (2017-2028) & (K MT)
Figure 27. Asia-Pacific Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Cancer Drugs Sales YoY (2017-2028) & (K MT)
Figure 29. Latin America Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Cancer Drugs Sales YoY (2017-2028) & (K MT)
Figure 31. Middle East & Africa Cancer Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Cancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Cancer Drugs in the World: Market Share by Cancer Drugs Revenue in 2021
Figure 34. Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 36. Global Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Global Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 39. North America Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 41. North America Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 43. North America Cancer Drugs Sales Share by Country (2017-2028)
Figure 44. North America Cancer Drugs Revenue Share by Country (2017-2028)
Figure 45. U.S. Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 49. Europe Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 50. Europe Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 51. Europe Cancer Drugs Sales Share by Country (2017-2028)
Figure 52. Europe Cancer Drugs Revenue Share by Country (2017-2028)
Figure 53. Germany Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. France Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Cancer Drugs Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Cancer Drugs Revenue Share by Region (2017-2028)
Figure 64. China Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. India Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 75. Latin America Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 77. Latin America Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Cancer Drugs Sales Share by Country (2017-2028)
Figure 79. Latin America Cancer Drugs Revenue Share by Country (2017-2028)
Figure 80. Mexico Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Cancer Drugs Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Cancer Drugs Revenue Share by Country (2017-2028)
Figure 89. Turkey Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. U.A.E Cancer Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. Cancer Drugs Value Chain
Figure 93. Cancer Drugs Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Novartis Celgene Bristol-Myers Squibb Amgen Johnson & Johnson Pfizer Takeda Eli Lilly AstraZeneca Astellas Merck & Co. Sanofi Bayer Biogen Idec Eisai Teva Otsuka Merck KGaA Ipsen AbbVie Gilead Sciences